Sanofi to acquire Austrian Origimm Biotechnology GmbH
VIENNA, AUSTRIA: Sanofi has entered into an agreement to acquire Origimm Biotechnology GmbH, a news release said. Origimm Biotechnology is an Austrian privately owned biotechnology company specializing in the discovery of virulent skin microbiome components and antigens from bacteria causing…